The Claim
Pharmacological inhibition of fructose metabolism or dietary reduction of fructose reduces tumor growth and enhances sensitivity to chemotherapy agents oxaliplatin and 5-fluorouracil in experimental models of colorectal cancer.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In laboratory models of colorectal cancer, blocking fructose metabolism or reducing dietary fructose decreases tumor growth and improves the effectiveness of chemotherapy drugs oxaliplatin and 5-fluorouracil.
See the scientific wording
In experimental models of colorectal cancer, pharmacological inhibition of fructose metabolism or dietary reduction of fructose reduces tumor growth and enhances sensitivity to chemotherapy agents such as oxaliplatin and 5-fluorouracil.
When glucose is low, colorectal cancer cells take in fructose using a specific transporter, then use an enzyme to convert it into energy and building blocks for growth. This process also protects the cancer cells from chemotherapy drugs. Blocking fructose intake or stopping this enzyme stops the energy supply, slows tumor growth, and makes chemotherapy more effective.
What the research says
1 studyIn mice and lab-grown human colon cancer cells, cutting off fructose (a sugar) or blocking how cancer cells use it made tumors grow slower and helped chemotherapy work better. This suggests reducing sugar intake or targeting fructose use could help treat colon cancer.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.